4DMedical Gains TGA Approval for CT:VQ Lung Imaging in Australia
4DMedical has received approval from the Australian Therapeutic Goods Administration for its CT:VQ imaging technology, according to a press release. The company will introduce the software in Australia, enabling ventilation and perfusion imaging without the use of contrast agents.
CT:VQ generates ventilation and perfusion data directly from routine non-contrast chest CT scans. The technology provides a software-based option that integrates with existing CT infrastructure, expanding access to functional lung assessment.
The TGA approval follows CT:VQ’s clearance by the U.S. Food and Drug Administration in 2025, where it has been deployed in leading medical institutions.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Brainomix and Pulmonary Fibrosis Foundation Partner on AI Lung Imaging Research
EDDA Technology Named to TIME HealthTech List for Second Year
Medical Image Analysis Software Market Forecast to Reach $6.3 Billion by 2031
LUNGevity Awards $2 Million for Lung Nodule Risk Studies
Taiwanese Health Technology Groups Test US Market in Dallas
Daily AI Brief: the AI news that matters, in your inbox.